Reducing hot flashes in women on hormone therapy for breast cancer
Treatments studied
Part of Cancer, Skin clinical trials.
This trial tests a new approach to reduce hot flashes in women taking hormone therapy for breast cancer. You may be able to join if you have at least 14 hot flashes a week and are not taking certain other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older, and you are pre-, peri-, or postmenopausal.
- You have been on breast cancer hormone therapy (like tamoxifen or an aromatase inhibitor) for at least 4 weeks and plan to continue.
- You have had hot flashes for at least 1 month, with 14 or more per week, and want to try medication for them.
- You are not pregnant or breastfeeding.
- You have not used antidepressants (like venlafaxine) or St. John's wort in the past year.
- You have not taken gabapentin, calcium channel blockers, or oxybutynin recently for hot flashes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether acupuncture can reduce hot flashes in people with hormone receptor-positive breast cancer who are on hormone therapy. If you've been having frequent hot flashes for at least 6 weeks, this study might help you find relief without medication.
This study tests whether acupuncture can reduce hot flashes in people with hormone-receptor-positive breast cancer who are on hormone therapy. If you've been struggling with frequent hot flashes, this treatment may help ease them.
This trial compares two medicines—solifenacin and clonidine—to see which one better reduces hot flashes in people taking hormone-blocking cancer medicines. If you have frequent hot flashes, joining could help researchers find an effective option for symptom relief.
This trial is testing whether acupuncture can help reduce hot flashes caused by hormone therapy for breast cancer. If you are struggling with frequent hot flashes, this study may offer a non-drug option to help you feel more comfortable.
This study tests a new treatment for women going through menopause who have frequent hot flashes. It aims to find a safe and effective way to reduce moderate to severe hot flashes.
This study tests a medication called fezolinetant to see if it helps with hot flashes and also looks at its effects on blood vessels and the brain. It is for women who are going through menopause and having frequent moderate to severe hot flashes.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.